In addition to SF3B1, another association between a gene defect and the ring sideroblasts phenotype was defined for PRPF8, for which mutations are reported in approximately 3% of myeloid neoplasms, including MDS, MDS/MPN, and secondary AML [145]. This evidence concerns the gene SF3B1 and myeloproliferative disorder.